GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Other Operating Expense

Sopharma AD-Sofia (WAR:SPH) Other Operating Expense : zł615 Mil (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Other Operating Expense?

Sopharma AD-Sofia's Other Operating Expense for the three months ended in Jun. 2024 was zł152 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was zł615 Mil.

Sopharma AD-Sofia's quarterly Other Operating Expense declined from Dec. 2023 (zł169 Mil) to Mar. 2024 (zł145 Mil) but then increased from Mar. 2024 (zł145 Mil) to Jun. 2024 (zł152 Mil).

Sopharma AD-Sofia's annual Other Operating Expense increased from Dec. 2021 (zł501 Mil) to Dec. 2022 (zł520 Mil) and increased from Dec. 2022 (zł520 Mil) to Dec. 2023 (zł579 Mil).


Sopharma AD-Sofia Other Operating Expense Historical Data

The historical data trend for Sopharma AD-Sofia's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Other Operating Expense Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 442.38 456.18 500.72 519.74 578.92

Sopharma AD-Sofia Quarterly Data
Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.95 148.37 168.83 144.98 152.33

Sopharma AD-Sofia Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł615 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma AD-Sofia Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.